BGLAP and Bardet-Biedl syndrome: Jeziorni et al. evaluated serum levels of osteocalcin (OC) and urinary deoxypyridinoline (DPD) levels, two bone markers indicating bone formation and bone resorption, respectively, in a cohort of 18 patients (11 with ALMS and 7 with BBS) [86].